Design Therapeutics, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 11.06 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 692.15M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Design Therapeutics, Inc. a clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. The company was incorporated in 2017 and is headquartered in Carlsbad, California.
Details
| Name | Design Therapeutics, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 55 |
| Founded | 2017 |
| Ipo Date | 2021-03-26 |
| Ceo | Pratik Shah |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 20.00 |
| Isin | US25056L1035 |
| Cusip | 25056L103 |
| Cik | 1807120 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Pratik Shah Ph.D. | Co-Founder, President, Chief Executive Officer, Principal Financial Officer and Executive Chairperson |
| Dr. Sean Jeffries Ph.D. | Chief Operating Officer |
| Dr. Chris M. Storgard M.D. | Chief Medical Officer |
| Dr. Aseem Z. Ansari Ph.D. | Co-Founder and Scientific Advisor |
| Julie D. Burgess CPA | Chief Accounting Officer |
| Doane Chilcoat Ph.D. | Chief Technology Officer |
| Mustapha Parekh | General Counsel |
| Dr. Tadimeti S. Rao Ph.D. | Chief Scientific Officer |
| Jim Kerr | Chief of Manufacturing and Product Development |
| Dr. Chengzhi Zhang Ph.D. | Chief Chemist |
Contact
| Address | 6005 Hidden Valley Road, Suite 110, Carlsbad, California 92011, United States |
| Phone | 858 293 4900 |
| Website | https://www.designtx.com |